Analysts Offer Insights on Healthcare Companies: Gamida Cell (GMDA) January 19 2022 - 08:36AM There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gamida Cell (GMDA – Research Report) and Acutus Medical (AFIB – Research Report) with bullish sentiments. Gamida Cell (GMDA) Needham analyst Gil Blum maintained a Buy rating on Gamida Cell today and set a price target of $12.00. The company's shares closed last Tuesday at $2.22, close to its 52-week low of $2.10. According to TipRanks. https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gamida-cell-gmda-and-acutus-medical-afib?utm_source=advfn.com&utm_medium=referral